PDB Entry - 6G91
(Status - Released)Summary information:
Title: Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2
PDB DOI: https://doi.org/10.2210/pdb6g91/pdb
Primary publication DOI: https://doi.org/10.1021/acs.jmedchem.8b00421
Entry authors: O'Reilly, M.
Initial deposition on: 10 April 2018
Initial release on: 30 May 2018
Latest revision on: 13 November 2024
Downloads:
Structure coordinates (PDBx/mmCIF)
Structure coordinates (PDBML)
Structure coordinates (PDB)
X-ray diffraction data (PDBx/mmCIF)
Validation report (mmCIF)
Validation report (PDF)
Validation report (XML)
Links to more resources for 6G91 at: